Differential effects of isoliquiritigenin and YC-1 in rat aortic smooth muscle

European Journal of Pharmacology

Volumn 323, Issue 1, 1997, Pages 89-91

  Wegener, Jörg W ^a   Nawrath, Hermann ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Guanylyl cyclase; Isoliquiritigenin; ODQ; Smooth muscle tension; YC 1

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 3 [5 HYDROXYMETHYL 2 FURYL] 1 BENZYL IMIDAZOLE; GUANYLATE CYCLASE; ISOLIQUIRITIGENIN; PHENYLEPHRINE; PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE TONE; VASCULAR RING;

ALDEHYDE REDUCTASE; ANIMALS; CAROTID ARTERIES; CHALCONE; CHALCONES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GUANYLATE CYCLASE; INDAZOLES; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; PHOSPHODIESTERASE INHIBITORS; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030943456     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00111-8     Document Type: Article

References (10)

1. Garthwaite, J., Southam, E., Boulton, C.L., Nielson, E.B., Schmidt, K., Mayer, B., 1995. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48, 184-188.
2. Ignarro, L.J., 1990. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30, 535-560.
3. Kontos, H.A., Wei, E.P., 1993. Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and by LY83583. Stroke 24, 427-434.
4. Kusano, A., Nikaido, T., Kuge, T., Ohmoto, T., Delle-Monache, G., Botta, B., Botta, M., Saitoh, T., 1991. Inhibition of adenosine 3′,5′-cyclic monophosphate phosphodiesterase by flavonoids from licorice roots and 4-arylcoumarins. Chem. Pharm. Bull. 39, 930-933.
5. Marshall, J.J., Wei, E.P., Kontos, H.A., 1988. Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide. Am. J. Physiol. 255, H847-H854.
6. Martin, W., Drazan, K.M., Newby, A.C., 1989. Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells. Br. J. Pharmacol. 97, 51-56.
7. Mayer, B., Brunner, F., Schmidt, K., 1993. Inhibition of nitric oxide synthesis by methylene blue. Biochem. Pharmacol. 45, 367-374.
8. Moro, M.A., Russel, R.J., Cellek, S., Lizasoain, I., Su, Y., Darley-Usmar, V.M., Radomski, M.W., Moncada, S., 1996. Cyclic GMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. USA 93, 1480-1485.
9. Wu, C.C., Ko, F.N., Kuo, S.C., Lee F.Y., Teng, C.M., 1995. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br. J. Pharmacol. 116, 1973-1978.
10. Yu, S.M., Kuo, S.C., 1995. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylyl cyclase activator, in rat aorta. Br. J. Pharmacol. 114, 1587-1594.